Changes in adherence and treatment costs following initiation of oral or depot typical antipsychotics among previously non‐adherent patients with schizophrenia

ConclusionsDepot formulations of typical antipsychotics appeared to improve medication adherence and reduce treatment costs, compared with oral formulations, in the treatment of non‐adherent patients. Limitation: adherence was assessed by the treating psychiatrist using a single‐item. Copyright © 2013 John Wiley & Sons, Ltd.

Source: Human Psychopharmacology: Clinical and Experimental - June 15, 2013 Category: Psychiatry Authors: Jihyung Hong, Diego Novick, Roberto Brugnoli, Jordan Bertsch, Josep Maria Haro Tags: Research Article Source Type: research